BDNF Levels in Blood of Huntington's Disease Patients
Author Information
Author(s): Zuccato Chiara, Marullo Manuela, Vitali Barbara, Tarditi Alessia, Mariotti Caterina, Valenza Marta, Lahiri Nayana, Wild Edward J., Sassone Jenny, Ciammola Andrea, Bachoud-Lèvi Anne Catherine, Tabrizi Sarah J., Di Donato Stefano, Cattaneo Elena
Primary Institution: Università degli Studi di Milano
Hypothesis
Can BDNF levels in blood serve as reliable biomarkers for Huntington's disease prognosis and progression?
Conclusion
The study concluded that BDNF levels in human blood are not reliable as biomarkers for Huntington's disease.
Supporting Evidence
- BDNF protein levels were not reliably different between controls and HD patients.
- Intra-group variability affected the measurement of BDNF levels.
- BDNF mRNA levels showed no significant differences among groups.
Takeaway
This study looked at a protein called BDNF in the blood of people with Huntington's disease and found it doesn't help us understand the disease better.
Methodology
The study measured BDNF levels in blood samples from controls, preHD, and HD subjects using ELISA and RT-qPCR.
Potential Biases
Intra-group variability and differences in sample collection methods may introduce bias.
Limitations
High variability in BDNF levels and methodological inconsistencies in sample preparation affected the results.
Participant Demographics
The study included 138 controls, 56 preHD, and 204 HD subjects.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website